Tadahiro Nambu
发表
Jon T. Willie,
T. Sakurai,
M. Yanagisawa,
2001,
Neuron.
D. Erion,
Tadahiro Nambu,
Kazunobu Aoyama,
2020,
PloS one.
T. Shimomura,
Tadahiro Nambu,
S. Inoue,
2004,
The Journal of investigative dermatology.
M. Okaniwa,
T. Kawamoto,
T. Ishikawa,
2016,
Bioorganic & medicinal chemistry letters.
M. Okaniwa,
T. Kawamoto,
Tadahiro Nambu,
2015,
PloS one.
Y. Terauchi,
T. Kadowaki,
N. Kubota,
2009,
Endocrinology.
M. Matsuda,
I. Shimomura,
T. Kitamura,
2004,
Journal of Biological Chemistry.
T. Shimomura,
Koji Ichikawa,
Shinichi Hasako,
2010,
Molecular Cancer Therapeutics.
Tadahiro Nambu,
S. Uehara,
T. Fukuroda,
2009,
Biochemical and biophysical research communications.
K. Iwata,
M. Okaniwa,
T. Kawamoto,
2015,
Nature Communications.
Tsuyoshi Arai,
Hiroshi Hirai,
Takashi Yoshizumi,
2009,
Molecular Cancer Therapeutics.
Takeshi Sakurai,
Katsuyoshi Mizukami,
Masashi Yanagisawa,
1999,
Brain Research.
T. Sakurai,
M. Yanagisawa,
T. Yada,
2000,
Brain Research.
R. Nishigaki,
A. Ando,
A. Nakamura,
2018,
Proceedings of the National Academy of Sciences.
A. Yamanaka,
K. Kunii,
T. Sakurai,
1999,
Brain Research.
T. Sakurai,
M. Yanagisawa,
K. Goto,
1999,
Neuroscience Letters.
Takao Inoue,
Tadahiro Nambu,
Yoshihiro Ogawa,
2011,
Life sciences.
A. Yamanaka,
K. Kunii,
T. Sakurai,
2000,
Brain Research.
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.
M. Klein,
R. Tjhen,
Biching Sang,
2019,
ACS medicinal chemistry letters.
K. Burke,
Jie Yu,
T. Miyazaki,
2019,
Science Advances.
A. Yamanaka,
M. Takigawa,
T. Sakurai,
2004,
The European journal of neuroscience.
K. Burke,
Jie Yu,
T. Miyazaki,
2019
.
Jie Yu,
S. Kageyama,
K. Kannan,
2021,
Science Advances.
T. Sakurai,
H. Iwaasa,
Megumi Shibahara,
1999,
Peptides.